Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms


Zhao G., Wang Y., Fan Z., Xiong J., ERTAŞ Y. N., Ashammakhi N., ...More

Cancer Letters, vol.591, 2024 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 591
  • Publication Date: 2024
  • Doi Number: 10.1016/j.canlet.2024.216860
  • Journal Name: Cancer Letters
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, Food Science & Technology Abstracts, Veterinary Science Database
  • Keywords: Apoptosis, Autophagy, Cancer therapy, Cell death, Nanoparticles
  • Erciyes University Affiliated: Yes

Abstract

Cancer is the result of genetic abnormalities that cause normal cells to grow into neoplastic cells. Cancer is characterized by several distinct features, such as uncontrolled cell growth, extensive spreading to other parts of the body, and the ability to resist treatment. The scientists have stressed the development of nanostructures as novel therapeutic options in suppressing cancer, in response to the emergence of resistance to standard medicines. One of the specific mechanisms with dysregulation during cancer is autophagy. Nanomaterials have the ability to specifically carry medications and genes, and they can also enhance the responsiveness of tumor cells to standard therapy while promoting drug sensitivity. The primary mechanism in this process relies on autophagosomes and their fusion with lysosomes to break down the components of the cytoplasm. While autophagy was initially described as a form of cellular demise, it has been demonstrated to play a crucial role in controlling metastasis, proliferation, and treatment resistance in human malignancies. The pharmacokinetic profile of autophagy modulators is poor, despite their development for use in cancer therapy. Consequently, nanoparticles have been developed for the purpose of delivering medications and autophagy modulators selectively and specifically to the cancer process. Furthermore, several categories of nanoparticles have demonstrated the ability to regulate autophagy, which plays a crucial role in defining the biological characteristics and response to therapy of tumor cells.